유럽 ​​중국 햄스터 난소(CHO) 세포 시장 규모, 점유율 및 동향 분석 보고서 – 산업 개요 및 2032년까지의 전망

TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 무료 샘플 보고서 무료 샘플 보고서 구매하기 전에 문의 구매하기 전에 문의 지금 구매 지금 구매

유럽 ​​중국 햄스터 난소(CHO) 세포 시장 규모, 점유율 및 동향 분석 보고서 – 산업 개요 및 2032년까지의 전망

  • Healthcare
  • Published Report
  • Dec 2023
  • Europe
  • 350 Pages
  • 테이블 수: 686
  • 그림 수: 46
  • Author : Sachin Pawar

민첩한 공급망 컨설팅으로 관세 문제를 극복하세요

공급망 생태계 분석이 이제 DBMR 보고서의 일부가 되었습니다

Europe Chinese Hamster Ovary Cells Cho Market

시장 규모 (USD 10억)

연평균 성장률 :  % Diagram

Chart Image USD 115.60 Million USD 205.49 Million 2024 2032
Diagram 예측 기간
2025 –2032
Diagram 시장 규모(기준 연도)
USD 115.60 Million
Diagram 시장 규모(예측 연도)
USD 205.49 Million
Diagram 연평균 성장률
%
Diagram 주요 시장 플레이어
  • Thermo Fisher Scientific Inc.
  • AcceGen
  • RayBiotech Life Inc.
  • Cytion
  • BPS Bioscience Inc.

유럽 ​​중국 햄스터 난소(CHO) 세포 시장 세분화: 유형(서비스 및 제품), 시스템(대사 선택 시스템, 항생제 선택 시스템 등), 응용 분야(생물학적 제제 및 의학 연구), 최종 사용자(바이오제약 회사, 생명공학 회사, 임상 개발 및 제조 기관, 임상 연구 기관, 학술 기관 및 연구 기관 등), 유통 채널(직접 입찰, 소매 판매 등) - 2032년까지 산업 동향 및 전망

유럽 ​​중국 햄스터 난소(CHO) 세포 시장

유럽 ​​중국 햄스터 난소(CHO) 세포 시장 규모

  • 유럽의 중국 햄스터 난소(CHO) 세포 시장은 2024년 1억 1,560만 달러 규모였으며 , 예측 기간 동안 연평균 10.1%의 성장률을 기록하여 2032년에는 2억 549만 달러 에 이를 것으로 예상됩니다 .
  • 이러한 성장은 생물학적 제제에 대한 수요 증가, 세포주 엔지니어링의 발전, 생명공학 연구에 대한 투자 증가, 유전자 치료 분야에서의 응용 확대와 같은 요인에 의해 주도되고 있습니다.
  • 또한, 세포주 엔지니어링, 공정 최적화 및 생물 생산 자동화 분야의 지속적인 기술 발전은 생산성과 제품 품질을 향상시키고 있습니다. 이러한 여러 요인들이 결합되어 생물학적 제제 개발에서 CHO 세포 활용이 가속화되고 있으며, 이는 시장 성장을 크게 촉진하고 있습니다.

유럽 ​​중국 햄스터 난소(CHO) 세포 시장 분석

  • 차이니즈 햄스터 난소(CHO) 세포는 생명공학 및 생의학 연구, 특히 세포 배양 및 생물공정 분야에서 널리 사용되는 포유류 세포주입니다. 이 세포는 생명공학 및 생의학 연구에서 필수적인 도구로 자리 잡았습니다. CHO 세포는 배양 표면에 잘 부착되고, 왕성한 성장 특성을 가지며, 재조합 단백질을 발현할 수 있는 능력이 있는 것으로 알려져 있습니다.
  • CHO 세포의 주요 용도 중 하나는 치료용 항체 및 효소를 포함한 재조합 단백질 생산입니다. CHO 세포는 특정 유전자를 발현하도록 유전적으로 조작할 수 있으며, 인간 세포와 유사하게 단백질 번역 후 변형을 수행할 수 있어 바이오 의약품의 품질을 보장합니다. 또한 CHO 세포는 유전적 안정성이 뛰어나 여러 세대에 걸쳐 유전자 변형이 일관되게 도입될 수 있으므로 생물공정의 신뢰성과 일관성을 보장합니다.
  • 2025년에는 독일이 18.05%의 시장 점유율로 유럽 중국 햄스터 난소(CHO) 세포 시장을 주도할 것으로 예상되며, 영국은 생물약품 연구 증가, 생물학적 제제 제조 역량 확대, 생명공학 투자 증가, 바이오시밀러 생산을 장려하는 정부 지원 정책 등에 힘입어 연평균 7.4%의 성장률로 가장 빠르게 성장하는 지역이 될 것으로 전망됩니다.
  • 2025년에는 CHO 세포주 개발, 바이오 공정 및 위탁 생산과 관련된 전문 서비스에 대한 수요 증가로 인해 서비스 부문이 66.28%의 시장 점유율로 시장을 주도할 것으로 예상됩니다.

보고서 범위 및 유럽 안과 수술 현미경 시장 세분화 

속성

유럽 ​​안과 수술 현미경 주요 시장 분석

포함되는 부문

  • 유형별 : 서비스 및 제품
  • 시스템별 분류 : 대사 선택 시스템, 항생제 선택 시스템 및 기타
  • 적용 분야 : 생물학 제제 및 의학 연구
  • 최종 사용자별 : 바이오제약 회사, 생명공학 회사, 임상 개발 및 제조 기관, 임상 연구 기관, 학술 기관 및 연구 기관, 기타
  • 유통 채널별 : 직접 입찰, 소매 판매 및 기타

대상 국가

유럽

  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 러시아 제국
  • 스페인
  • 칠면조
  • 네덜란드
  • 스위스
  • 오스트리아
  • 아일랜드
  • 노르웨이
  • 폴란드
  •  유럽의 나머지 지역

주요 시장 참여자

  • 써모 피셔 사이언티픽(미국)
  • AcceGen (미국)
  • 레이바이오텍 라이프(RayBiotech Life, Inc. ) (미국)
  • 시티온 (독일)
  • BPS 바이오사이언스 (미국)
  • 젠타겟(GenTarget Inc., 미국)
  • 머크 KGaA (독일)
  • 프로메가 코퍼레이션(미국)
  • 아베오믹스(미국)
  • Applied Biological Materials Inc.(캐나다)
  • ATCC(미국)
  • 사토리우스 AG(독일)
  • 론자(스위스)
  • 레비티 디스커버리 리미티드(미국)
  • 사이티바(미국)
  • GTP 바이오웨이즈(프랑스)
  • 큐리아 글로벌(Curia Global, Inc., 미국)
  • 애보트(미국)

시장 기회

  • 세포 배양 기술의 지속적인 발전
  • CHO 세포의 응용 분야 증가

부가가치 데이터 정보세트

데이터 브리지 마켓 리서치에서 제공하는 시장 보고서는 시장 가치, 성장률, 시장 세분화, 지역별 시장 범위, 주요 기업 등 시장 시나리오에 대한 심층 분석 외에도 수출입 분석, 생산 능력 개요, 생산 및 소비 분석, 가격 추세 분석, 기후 변화 시나리오, 공급망 분석, 가치 사슬 분석, 원자재/소모품 개요, 공급업체 선정 기준, PESTLE 분석, 포터 분석, 규제 체계 등을 포함합니다.

유럽 ​​중국 햄스터 난소(CHO) 세포 시장 동향

세포주 개발에 인공지능(AI)의 통합이 점차 확대되고 있다

  • 유럽 ​​중국 햄스터 난소(CHO) 세포 시장의 두드러진 추세 중 하나는 세포주 개발 및 생물공정 최적화에 인공지능(AI)이 점점 더 많이 통합되고 있다는 점입니다.
  • 인공지능 알고리즘은 대규모 데이터 세트를 분석하고, 최적의 배양 조건을 예측하며, 기존 방식보다 효율적으로 고수율 클론을 식별하는 데 사용되고 있습니다.
  • 예를 들어, 머신러닝 모델은 실험 데이터를 처리하여 세포 성능을 예측함으로써 CHO 세포 기반 생산에서 시행착오 방식에 소요되는 시간과 비용을 줄일 수 있습니다.
  • 이 기술은 생물학적 제제 제조에 있어 개발 기간 단축, 제품 품질 향상 및 확장성 증대를 가능하게 합니다.
  • 인공지능(AI)의 활용은 CHO 세포 연구 및 바이오 제조 분야를 혁신하고 있으며, 효율성 증대, 개발 비용 절감, 그리고 첨단 디지털 솔루션을 도입하는 기업들에게 경쟁력 강화라는 이점을 제공하고 있습니다.

유럽 ​​중국 햄스터 난소(CHO) 세포 시장 동향

운전사

"유전학 연구에서 CHO 세포 사용 증가"

  • 유전 연구에서 차이니즈 햄스터 난소(CHO) 세포의 활용이 증가함에 따라 유럽 CHO 시장의 성장이 가속화되고 있습니다. CRISPR, RMCE, RNA-seq, 단일 세포 다중 오믹스 등의 유전 도구가 발전하면서 CHO 세포는 더 이상 단순한 생산 숙주가 아닌, 유전자형-표현형 관계 분석, 유전자 편집 전략 테스트, 그리고 숙주 특성(성장, 생산성, 당화, 스트레스 내성)의 합리적인 설계를 위한 실험 플랫폼으로 활용되고 있습니다.
  • 이러한 변화는 서로 연관된 세 가지 시장 분야, 즉 (1) 상류 부문(라이선스/엔지니어링된 CHO 세포주 및 유전자 편집 서비스), (2) 공정 개발 부문(유전적 통찰력을 안정적이고 수율이 높은 클론으로 전환하는 데 필요한 분석, 오믹스, 디지털 트윈 및 AI 도구), (3) 제조 부문(CDMO 역량 및 유전적으로 강화된 숙주에 최적화된 일회용/연속 생산 플랫폼) 전반에 걸쳐 수요를 확대합니다.
  • 요컨대, 유전학 연구 활동은 확장되는 생태계(소프트웨어, 분석, 세포 은행, 시약, CDMO 운영)에 활력을 불어넣어 상업용 CHO 세포의 종류와 종류를 다양화하고, 결과적으로 CHO 세포 유래 제조 역량의 시장 규모, 매출, 전략적 중요성을 증대시킵니다.
  • 예를 들어, 2025년 1월 NIH에 발표된 한 논문에서는 CHO-K1 세포 및 유래 재조합 세포에 대한 게놈 규모의 비바이러스성 CRISPR 유전자 제거 스크리닝 데이터 세트가 공개되었다고 밝혔습니다(Sci Data). 이 데이터 세트는 세포 적합성과 단백질 생산에 영향을 미치는 유전자를 식별하는 데 필요한 포괄적인 자료를 제공하며, CHO 세포에서의 기능적 유전체 스크리닝이 이제 성숙 단계에 접어들어 공개적으로 문서화되었고, 세포 공학 프로그램에 직접적인 정보를 제공하고 있음을 보여줍니다.
  • 2025년 4월, NIH에서 발표된 논문에 따르면 CHO 세포 전사체에 대한 메타 분석 연구("Fantastic genes…")가 2025년 초 수정 후 PMC(오픈 액세스)에 게재 승인되었습니다. 이 논문은 수백 개의 CHO 샘플에서 얻은 RNA-seq 및 후성유전학적 데이터를 통합하여 발현 프로그램을 제어하기 위한 표적 유전자 공학의 필요성을 강조합니다. 이는 CHO 세포의 유전체/후성유전체 연구가 산업적 세포주 개량을 위한 유전자 공학적 목표를 설정하고 있음을 보여주는 직접적인 증거입니다.
  • 유전학 연구에서 CHO 세포의 사용이 증가함에 따라 생물학적 제제 발현 시스템의 표준으로서의 입지가 더욱 강화될 뿐만 아니라 기능 유전체학, 규제 시험 및 세포 공학을 위한 실험 플랫폼으로서의 역할도 확대되고 있습니다.

절제/도전

"CHO 세포 기반 생산의 높은 비용이 시장 제약 요인으로 작용"

  • CHO 세포 기반 바이오 의약품 생산과 관련된 높은 자본 및 운영 비용은 유럽 CHO 세포 시장의 주요 제약 요인입니다.
  • 바이오리액터 용량, 클린룸, 일회용 시스템 또는 스테인리스강 기반 시설, 그리고 특수 하류 정제 장비에 대한 대규모 초기 투자와 더불어 고가의 원자재(배지, 크로마토그래피 수지), 숙련된 인력, 복잡한 규제 준수 및 긴 검증 기간은 제조업체와 CDMO의 총 소유 비용을 증가시킵니다.
  • 이러한 비용 압박은 제품 출시 기간을 늘리고, 마진을 압축하며, 소규모 개발업체의 자체 생산을 저해하고, 저소득 지역에서의 도입을 늦출 수 있습니다. 이러한 모든 요인들은 CHO 플랫폼과 관련된 새로운 세포주, 소모품 및 서비스 계약에 대한 수요를 제약합니다.
  • 예를 들어, 2025년 7월 미국 보건복지부 산하 기획평가차관보실(HHS-ASPE)은 생물학적 제제에 대한 지출이 크게 증가하고 있으며, 생물학적 제제의 복잡성과 비용 구조(개발 및 제조)가 의약품 지출 증가의 주요 원인이라고 지적하는 보고서를 발표했습니다. 이는 생물학적 제제/CHO 제조 비용이 경제적 제약 요인으로 작용한다는 점을 강조합니다.
  • 2024년 3월, 유럽 위원회는 정책 및 연구 자료(공동 연구 센터/연구혁신총국 분석)를 발표하여 생명공학 및 바이오 제조에는 고도로 전문화된 장비와 숙련된 다분야 인력이 필요하며, 이러한 요소들이 제조 단위 비용을 증가시키고 EU 전역으로 생산 규모를 확대하는 데 장벽이 된다고 지적했습니다.
  • 치료용 단백질 및 단일클론 항체 생산의 표준으로 여겨지는 CHO 세포 기반 제조 방식은 높은 비용 구조로 인해 여전히 상당한 제약을 받고 있습니다. 자본 집약적인 인프라 구축, 고가의 원자재, 전문 인력 필요성, 엄격한 규제 준수 절차 등으로 인해 전반적인 생산 비용이 증가하여 소규모 기업의 참여가 제한되고 신흥 시장 진출이 저해되고 있습니다.

유럽 ​​중국 햄스터 난소(CHO) 세포 시장 전망

시장은 유형, 시스템, 애플리케이션, 최종 사용자 및 유통 채널을 기준으로 세분화됩니다.

  • 유형별로

시장은 유형별로 서비스, 제품 및 기타로 구분됩니다. 2025년에는 서비스 부문이 66.28%의 시장 점유율로 시장을 주도하며, 연평균 성장률(CAGR) 7.7%로 가장 빠르게 성장할 것으로 예상됩니다. 이러한 성장은 특수 세포주 개발, 공정 최적화 및 대규모 바이오 제조를 위해 임상시험수탁기관(CRO)과 위탁개발생산기관(CDMO)에 대한 의존도가 증가하고 있기 때문입니다. 또한, 바이오의약품 생산의 복잡성 증가, 자체 시설 운영 비용 상승, 맞춤형 솔루션에 대한 수요 증가는 제약 및 생명공학 기업들이 서비스 아웃소싱을 확대하도록 유도하고 있습니다. 이러한 요인들이 종합적으로 서비스 부문의 확장을 견인하여 예측 기간 동안 시장 점유율과 성장 잠재력을 높일 것으로 전망됩니다.

  • 시스템별

시스템을 기준으로 시장은 대사 선택 시스템, 항생제 선택 시스템 및 기타로 세분화됩니다. 2025년에는 대사 선택 시스템 부문이 59.11%의 시장 점유율로 시장을 주도하며 연평균 7.8%의 성장률로 가장 빠르게 성장할 것으로 예상됩니다. 이러한 성장은 안정적이고 고수율의 재조합 단백질 생산을 위한 대사 선택 시스템의 도입 증가에 주로 기인합니다. 대사 선택 시스템은 항생제 내성 마커의 필요성을 없애고, 규제 관련 우려를 줄이며, 배양 효율을 향상시키기 때문입니다. 또한, 생물학적 제제 및 바이오시밀러 제조에서 더욱 안전하고 비용 효율적이며 확장 가능한 세포주 개발 기술에 대한 선호도가 높아지고 있는 것도 이 부문의 성장을 뒷받침합니다.

  • 신청을 통해

응용 분야를 기준으로 시장은 바이오의약품과 의료 연구 부문으로 구분됩니다. 2025년에는 바이오의약품 부문이 72.12%의 시장 점유율로 시장을 주도하며 연평균 7.7%의 성장률을 기록할 것으로 예상됩니다. 이러한 성장은 치료용 단백질, 단클론 항체, 백신에 대한 수요 증가와 만성 및 자가면역 질환의 유병률 증가에 기인합니다. 또한, 생물공정 기술의 발전, 바이오의약품 연구개발 투자 확대, 고품질의 확장 가능한 바이오의약품 생산을 위한 차이니즈 햄스터 난소(CHO) 세포의 활용 증가 등이 바이오의약품 부문의 시장 지배력과 빠른 성장을 더욱 촉진하고 있습니다.

  • 최종 사용자에 의해

최종 사용자를 기준으로 시장은 바이오제약 회사, 생명공학 회사, 임상 개발 및 제조 기관, 임상 연구 기관, 학술 기관 및 연구 기관, 그리고 기타로 세분화됩니다. 2025년에는 바이오제약 회사 부문이 44.37%의 점유율로 시장을 주도할 것으로 예상됩니다. 이러한 주도권은 바이오제약 회사들이 생물학적 제제, 단클론 항체, 유전자 치료제 개발에 점점 더 집중하고 있기 때문이며, 이러한 제품들은 고수율 및 고품질 단백질 생산을 위해 CHO 세포와 같은 첨단 세포주에 크게 의존합니다. 또한, 연구 개발 투자 증가, 생물학적 제제 파이프라인 확장, 그리고 확장 가능하고 비용 효율적인 생산 공정에 대한 필요성 또한 바이오제약 회사의 시장 선도적 지위를 더욱 강화하고 있습니다.

  • 유통 채널

유통 채널을 기준으로 시장은 직접 입찰, 소매 판매 및 기타로 구분됩니다. 2025년에는 직접 입찰 부문이 82.23%의 시장 점유율로 시장을 주도할 것으로 예상되며, 소매 판매 부문은 연평균 성장률(CAGR) 6.4%로 가장 빠르게 성장할 것으로 전망됩니다. 직접 입찰의 성장은 비용 효율성, 안정적인 공급 및 장기 계약을 추구하는 대형 바이오제약 및 연구 기관의 대량 구매에 기인합니다. 한편, 소매 판매의 빠른 성장은 소규모 연구실 및 학술 기관의 연구 제품 접근성 향상, 즉시 사용 가능한 키트에 대한 수요 증가, 과학 용품 전자상거래 플랫폼의 확장으로 다양한 최종 사용자가 제품을 더욱 쉽게 이용할 수 있게 된 데 힘입은 것입니다.

유럽 ​​중국 햄스터 난소(CHO) 세포 시장 지역 분석

  • 유럽은 탄탄한 바이오 제약 산업, 선진 의료 인프라, 그리고 주요 제약 및 생명공학 기업들의 강력한 입지에 힘입어 전 세계 CHO 세포 시장에서 29.38%의 점유율을 차지하고 있습니다.
  • 특히 미국은 높은 연구 개발 투자, 생물학적 제제에 대한 수요 증가, 그리고 단일클론 항체와 같은 치료용 단백질 생산에 CHO 세포를 광범위하게 사용하는 덕분에 이 지역의 지배력에 크게 기여하고 있습니다.
  • 정부의 생물학적 제제 개발 지원과 견고한 규제 체계, 유리한 상환 정책은 시장 성장을 더욱 가속화합니다. 또한 전략적 협력, 세포주 개발의 기술 발전, CHO 세포 유래 제품에 대한 FDA 승인 증가 등이 이 지역 전반에 걸쳐 시장 확대를 촉진하고 있습니다 .

독일 CHO 세포 시장 분석

  • 독일의 CHO 세포 시장은 2025년 유럽 CHO 세포 시장에서 가장 큰 시장 매출 점유율을 차지할 것으로 예상됩니다. 이는 독일의 탄탄한 바이오 제약 산업, 상당한 연구 개발 투자, 주요 생명공학 및 제약 회사의 존재, 선진적인 생물학적 제제 제조 인프라, 그리고 세포주 개발 및 생물학적 제제 생산 혁신에 대한 강력한 정부 지원에 기인합니다.

영국 CHO 세포 시장 분석

  • 영국 CHO 세포 시장은 생물약학 연구에 대한 투자 증가, 첨단 세포주 기술 도입 확대, 바이오의약품 및 바이오시밀러 생산 시설 확장, 그리고 생명공학 및 생명과학 혁신을 촉진하는 정부 지원 정책에 힘입어 2025년부터 2032년까지 유럽에서 상당한 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다.

유럽 ​​중국 햄스터 난소(CHO) 세포 시장 점유율

시장 경쟁 환경 분석은 경쟁업체별 상세 정보를 제공합니다. 여기에는 회사 개요, 재무 정보, 매출, 시장 잠재력, 연구 개발 투자, 신규 시장 진출 전략, 유럽 시장 진출 현황, 생산 시설 및 공장, 생산 능력, 강점과 약점, 신제품 출시, 제품 범위 및 다양성, 시장 지배력 등이 포함됩니다. 위에 제공된 데이터는 해당 기업의 시장 집중 분야와 관련된 정보만을 담고 있습니다.

해당 시장에서 활동하는 주요 시장 선도 기업은 다음과 같습니다.

  • 써모 피셔 사이언티픽(미국)
  • AcceGen(미국)
  • 레이바이오텍 라이프(미국)
  • 시티온(독일)
  • BPS 바이오사이언스(미국)
  • 젠타겟(GenTarget Inc., 미국)
  • 머크 KGaA (독일)
  • 프로메가 코퍼레이션(미국)
  • 아베오믹스(미국)
  • Applied Biological Materials Inc.(캐나다)
  • ATCC(미국)
  • 사토리우스 AG(독일)
  • 론자(스위스)
  • 레비티 디스커버리 리미티드(미국)
  • 사이티바(미국)
  • GTP 바이오웨이즈(프랑스)
  • 큐리아 글로벌(Curia Global, Inc., 미국)
  • 애보트(미국)

유럽의 중국 햄스터 난소(CHO) 세포 최신 연구 동향

  • 2022년 2월, 사토리우스는 노바셉의 사업 부문을 인수하여 크로마토그래피 포트폴리오에 보완적인 제품을 추가했습니다. 인수된 포트폴리오에는 올리고뉴클레오티드, 펩타이드, 인슐린과 같은 소형 생체 분자에 주로 적합한 크로마토그래피 시스템과 바이오 의약품의 연속 생산을 위한 혁신적인 시스템이 포함됩니다.
  • 2023년 7월, 론자는 GS-CHO 세포주를 사용할 때 공정을 간소화하고 생산성 및 단백질 품질을 최적화하는 새로운 세포 배양 배지인 TheraPRO CHO Media System을 출시했습니다. 이 스타트업은 치료용 단백질을 생산하는 제약 및 바이오테크 기업의 제품 품질 향상을 지원합니다. TheraPRO CHO Media System은 효율적인 성능을 제공하여 15일 배양 기간 동안 높은 농도의 생존 세포와 5g/L 이상의 단백질 수율을 달성합니다. 이는 시판 제품으로 생산할 수 있는 단백질 수율의 두 배 이상에 해당합니다. 이 출시를 통해 론자는 시장에서 제품 포트폴리오를 확장할 수 있었습니다.
  • 2022년 10월, 써모 피셔 사이언티픽(Thermo Fisher Scientific Inc.)은 프로바이오젠(ProBioGen)과 협력하여 깁코 프리덤 엑스피초-S 세포주 개발 키트(Gibco Freedom ExpiCHO-S Cell Line Development Kit)의 플랫폼을 개선했습니다. 이 키트를 사용하면 사용자는 자체 세포, 벡터 또는 관련 분야 경험 없이도 임상 개발에 적합한 세포주를 생성할 수 있습니다. 프로바이오젠은 세포주 및 공정 개발 분야의 풍부한 전문성을 활용하여 프리덤 엑스피초-S 키트의 성능 향상에 크게 기여했습니다. 이 새로운 시리즈는 써모 피셔의 엑스피초-S 세포주를 활용하여 CHO 세포주 개발 제품군을 확장합니다.
  • 2023년 7월, 머크는 미국 캔자스주 레넥사에 위치한 시설을 확장하여 9,100제곱미터 규모의 실험실 공간과 세포 배양 배지 생산 능력을 증설한다고 발표했습니다. 이번 확장을 통해 레넥사 시설은 머크의 최대 규모 건조 분말 세포 배양 시설이자 북미 지역 내 핵심 연구 센터로 자리매김하게 되었습니다. 이 지역에 대한 투자는 세포 배양 플랫폼에 대한 현재 및 미래의 수요를 충족하기 위해 공급망을 확장하고 다변화하려는 머크의 전략을 반영합니다.
  • 2022년 11월, 생물학적 물질 분야의 세계적인 규제 및 표준 기관인 ATCC는 면역항암제 발굴 및 새로운 면역요법 개발을 지원하기 위해 새로운 CAR-T 표적 루시페라제 리포터 세포주 제품군을 발표했습니다. 이 모델들은 HER2, CD19, CD20과 같은 관련 키메라 항원 수용체(CAR) T 표적 항원을 높은 수준으로 내재 발현합니다. 이러한 새로운 면역항암제 개발 도구는 루시페라제 리포터를 발현하는 혈액암 및 고형암 세포주로 구성되어 있으며, 이를 통해 해당 기업은 제품 포트폴리오를 확장할 수 있었습니다.


SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 MARKET APPLICATION COVERAGE GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTER'S FIVE FORCES ANALYSIS

4.3 PATENT ANALYSIS – EUROPE CHO CELLS MARKET

4.3.1 PATENT QUALITY AND STRENGTH

4.3.2 PATENT FAMILIES

4.3.3 LICENSING AND COLLABORATIONS

4.3.4 COMPETITIVE LANDSCAPE

4.3.5 IP STRATEGY AND MANAGEMENT

4.3.6 OTHER OBSERVATIONS

4.4 INDUSTRY INSIGHTS

4.4.1 MICRO AND MACRO ECONOMIC FACTORS

4.4.2 PENETRATION AND GROWTH PROSPECT MAPPING

4.4.3 KEY PRICING STRATEGIES

4.5 INNOVATION TRACKER AND STRATEGIC ANALYSIS

4.5.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS

4.5.1.1 JOINT VENTURES

4.5.1.2 MERGERS AND ACQUISITIONS

4.5.1.3 LICENSING AND PARTNERSHIP

4.5.1.4 TECHNOLOGY COLLABORATIONS

4.5.1.5 STRATEGIC DIVESTMENTS

4.5.2 NUMBER OF PRODUCTS IN DEVELOPMENT

4.5.3 STAGE OF DEVELOPMENT

4.5.4 TIMELINES AND MILESTONES

4.5.5 INNOVATION STRATEGIES AND METHODOLOGIES

4.5.6 RISK ASSESSMENT AND MITIGATION

4.5.7 FUTURE OUTLOOK

4.6 OPPORTUNITY MAP

4.7 PRICING ANALYSIS – EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET

4.8 RAW MATERIAL COVERAGE

4.9 VALUE CHAIN ANALYSIS

4.1 CONSUMER BUYING BEHAVIOUR

4.11 TECHNOLOGICAL ADVANCEMENTS

5 TARIFFS & IMPACT ON THE MARKET

5.1 CURRENT TARIFF RATE

5.2 OUTLOOK — LOCAL PRODUCTION VS. IMPORT RELIANCE

5.3 VENDOR SELECTION CRITERIA DYNAMICS

5.4 IMPACT ON SUPPLY CHAIN

5.4.1 RAW MATERIAL PROCUREMENT

5.4.2 MANUFACTURING AND PRODUCTION

5.4.3 LOGISTICS AND DISTRIBUTION

5.4.4 PRICE PITCHING AND MARKET POSITION

5.5 INDUSTRY PARTICIPANTS

5.5.1 SUPPLY CHAIN OPTIMIZATION

5.5.2 JOINT VENTURE AND LOCAL PARTNERSHIPS

5.6 IMPACT ON PRICES

5.7 REGULATORY INCLINATION

5.7.1 GEOPOLITICAL SITUATION

5.7.2 TRADE PARTNERSHIPS BETWEEN COUNTRIES

5.7.2.1 FREE TRADE AGREEMENTS

5.7.2.2 ALLIANCES ESTABLISHMENTS

5.7.3 STATUS ACCREDITATION (INCLUDING MFN)

5.7.4 DOMESTIC COURSE OF CORRECTION

5.7.4.1 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS

5.7.4.2 ESTABLISHMENT OF SPECIAL ECONOMIC ZONES / INDUSTRIAL PARKS

6 REGULATORY FRAMEWORK – EUROPE CHO CELLS MARKET

6.1 NORTH AMERICA

6.2 EUROPE

6.3 ASIA-PACIFIC

6.4 SOUTH AMERICA

6.5 MIDDLE EAST & AFRICA

7 MARKET OVERVIEW

7.1 DRIVER

7.1.1 RISING USE OF CHO CELLS IN THE GENETIC STUDY

7.1.2 GROWING DEMAND FOR BIOPHARMACEUTICALS

7.1.3 RISING INVESTMENTS IN BIOTECHNOLOGY R&D

7.1.4 RISING DEMAND FOR MONOCLONAL ANTIBODIES

7.2 RESTRAINT

7.2.1 HIGH COST OF CHO CELL–BASED PRODUCTION AS A MARKET RESTRAINT

7.2.2 STRICT REGULATORY REQUIREMENTS FOR CHO CELL-BASED PRODUCTION

7.3 OPPORTUNITY

7.3.1 CONTINUOUS DEVELOPMENT OF CELL-CULTURE TECHNOLOGIES

7.3.2 RISING NUMBER OF APPLICATIONS OF CHO CELLS

7.3.3 ADVANCES IN CELL-LINE ENGINEERING & SYNTHETIC BIOLOGY

7.4 CHALLENGES

7.4.1 TIME-CONSUMING AND INCONSISTENCY IN CHO CELL LINE DEVELOPMENT PROCESS

7.4.2 CONTAMINATION RISK OF CHO CELL CULTURES

8 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE

8.1 OVERVIEW

8.2 SERVICES

8.3 PRODUCT

8.3.1 CHO-K1

8.3.1.1 CHO-K1 ATCC

8.3.1.2 CHO-K1 ECACC

8.3.1.3 Others

8.3.2 CHO-DG44

8.3.3 CHO-S

8.3.4 CHO-DXB11

8.3.5 OTHERS

9 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM

9.1 OVERVIEW

9.2 METABOLIC SELECTION SYSTEM

9.3 ANTIBIOTIC SELECTION SYSTEM

9.4 OTHERS

10 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION

10.1 OVERVIEW

10.2 BIOLOGICS

10.2.1 MONOCLONAL ANTIBODIES

10.2.2 FC-FUSION PROTIEN

10.2.3 ENZYMES

10.2.4 HORMONES

10.2.5 CYTOKINES

10.2.6 CLOTTING FACTORS

10.2.7 OTHERS

10.3 MEDICAL RESEARCH

11 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER

11.1 OVERVIEW

11.2 BIOPHARMACEUTICAL COMPANIES

11.2.1 MEDIUM

11.2.2 SMALL

11.3 CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS

11.3.1 MEDIUM

11.3.2 SMALL

11.4 BIOTECHNOLOGY COMPANIES

11.4.1 MEDIUM

11.4.2 SMALL

11.5 ACADEMIC INSTITUTES AND RESEARCH ORGANIZATIONS

11.6 CLINICAL RESEARCH ORGANIZATIONS

11.6.1 MEDIUM

11.6.2 SMALL

11.7 OTHERS

12 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL

12.1 OVERVIEW

12.2 DIRECT TENDERS

12.3 RETAIL SALES

12.4 OTHERS

13 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION

13.1 EUROPE

13.1.1 GERMANY

13.1.2 U.K.

13.1.3 FRANCE

13.1.4 ITALY

13.1.5 SPAIN

13.1.6 SWITZERLAND

13.1.7 NETHERLANDS

13.1.8 BELGIUM

13.1.9 SWEDEN

13.1.10 DENMARK

13.1.11 RUSSIA

13.1.12 TURKEY

13.1.13 NORWAY

13.1.14 FINLAND

13.1.15 REST OF EUROPE

14 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: EUROPE

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 SARTORIUS AG

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENT

16.2 LONZA

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENT

16.3 THERMO FISHER SCIENTIFIC INC.

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENT

16.4 CYTIVA

16.4.1 COMPANY SNAPSHOT

16.4.2 COMPANY SHARE ANALYSIS

16.4.3 PRODUCT PORTFOLIO

16.4.4 RECENT DEVELOPMENT

16.5 MERCK KGAA

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 COMPANY SHARE ANALYSIS

16.5.4 PRODUCT PORTFOLIO

16.5.5 RECENT DEVELOPMENT

16.6 ABEOMICS

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENT

16.7 ACCEGEN

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENT

16.8 APPLIED BIOLOGICAL MATERIALS INC. (ABM)

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENT

16.9 ATCC

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENT

16.1 BPS BIOSCIENCE, INC.

16.10.1 COMPANY SNAPSHOT

16.10.2 PRODUCT PORTFOLIO

16.10.3 RECENT DEVELOPMENT

16.11 CYTION

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENT

16.12 CURIA GLOBAL, INC.

16.12.1 COMPANY SNAPSHOT

16.12.2 SERVICE PORTFOLIO

16.12.3 RECENT DEVELOPMENT

16.13 GENTARGET INC.

16.13.1 COMPANY SNAPSHOT

16.13.2 PRODUCT PORTFOLIO

16.13.3 RECENT DEVELOPMENT

16.14 GTP BIOWAYS

16.14.1 COMPANY SNAPSHOT

16.14.2 PRODUCT PORTFOLIO

16.14.3 RECENT DEVELOPMENT

16.15 PROMEGA CORPORATION

16.15.1 COMPANY SNAPSHOT

16.15.2 PRODUCT PORTFOLIO

16.15.3 RECENT DEVELOPMENT

16.16 RAYBIOTECH LIFE, INC.

16.16.1 COMPANY SNAPSHOT

16.16.2 PRODUCT PORTFOLIO

16.16.3 RECENT DEVELOPMENT

16.17 REVVITY DISCOVERY LIMITED.

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENT

17 QUESTIONNAIRE

18 RELATED REPORTS

표 목록

TABLE 1 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 2 EUROPE SERVICES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 3 EUROPE PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 4 EUROPE PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 5 EUROPE CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 6 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 7 EUROPE METABOLIC SELECTION SYSTEM IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 8 EUROPE ANTIBIOTIC SELECTION SYSTEM IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 9 EUROPE OTHERS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 10 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 11 EUROPE BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 12 EUROPE BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 13 EUROPE MEDICAL RESEARCH IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 14 EUROPE CHINESE HAMSTER OVARY CELLS CHO MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 15 EUROPE BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 16 EUROPE BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 17 EUROPE CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 18 EUROPE CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 19 EUROPE BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 20 EUROPE BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 21 EUROPE ACADEMIC INSTITUTES AND RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 22 EUROPE CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 23 EUROPE CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 24 EUROPE OTHERS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 25 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 26 EUROPE DIRECT TENDERS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 27 EUROPE RETAIL SALES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 28 EUROPE OTHERS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 29 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 30 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 31 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 32 NORTH AMERICA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 33 NORTH AMERICA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 34 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 35 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 36 NORTH AMERICA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 37 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 38 NORTH AMERICA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 39 NORTH AMERICA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 40 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 41 NORTH AMERICA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 42 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 43 U.S. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 44 U.S. PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 45 U.S. CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 46 U.S. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 47 U.S. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 48 U.S. BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 49 U.S. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 50 U.S. BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 51 U.S. CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 52 U.S. BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 53 U.S. CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 54 U.S. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 55 CANADA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 56 CANADA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 57 CANADA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 58 CANADA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 59 CANADA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 60 CANADA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 61 CANADA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 62 CANADA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 63 CANADA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 64 CANADA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 65 CANADA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 66 CANADA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 67 MEXICO CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 68 MEXICO PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 69 MEXICO CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 70 MEXICO CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 71 MEXICO CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 72 MEXICO BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 73 MEXICO CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 74 MEXICO BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 75 MEXICO CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 76 MEXICO BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 77 MEXICO CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 78 MEXICO CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 79 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 80 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 81 EUROPE PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 82 EUROPE CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 83 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 84 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 85 EUROPE BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 86 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 87 EUROPE BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 88 EUROPE CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 89 EUROPE BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 90 EUROPE CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 91 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 92 GERMANY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 93 GERMANY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 94 GERMANY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 95 GERMANY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 96 GERMANY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 97 GERMANY BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 98 GERMANY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 99 GERMANY BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 100 GERMANY CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 101 GERMANY BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 102 GERMANY CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 103 GERMANY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 104 U.K. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 105 U.K. PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 106 U.K. CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 107 U.K. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 108 U.K. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 109 U.K. BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 110 U.K. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 111 U.K. BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 112 U.K. CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 113 U.K. BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 114 U.K. CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 115 U.K. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 116 FRANCE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 117 FRANCE PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 118 FRANCE CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 119 FRANCE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 120 FRANCE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 121 FRANCE BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 122 FRANCE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 123 FRANCE BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 124 FRANCE CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 125 FRANCE BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 126 FRANCE CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 127 FRANCE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 128 ITALY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 129 ITALY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 130 ITALY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 131 ITALY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 132 ITALY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 133 ITALY BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 134 ITALY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 135 ITALY BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 136 ITALY CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 137 ITALY BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 138 ITALY CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 139 ITALY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 140 SPAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 141 SPAIN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 142 SPAIN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 143 SPAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 144 SPAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 145 SPAIN BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 146 SPAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 147 SPAIN BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 148 SPAIN CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 149 SPAIN BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 150 SPAIN CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 151 SPAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 152 SWITZERLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 153 SWITZERLAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 154 SWITZERLAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 155 SWITZERLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 156 SWITZERLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 157 SWITZERLAND BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 158 SWITZERLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 159 SWITZERLAND BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 160 SWITZERLAND CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 161 SWITZERLAND BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 162 SWITZERLAND CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 163 SWITZERLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 164 NETHERLANDS CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 165 NETHERLANDS PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 166 NETHERLANDS CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 167 NETHERLANDS CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 168 NETHERLANDS CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 169 NETHERLANDS BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 170 NETHERLANDS CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 171 NETHERLANDS BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 172 NETHERLANDS CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 173 NETHERLANDS BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 174 NETHERLANDS CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 175 NETHERLANDS CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 176 BELGIUM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 177 BELGIUM PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 178 BELGIUM CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 179 BELGIUM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 180 BELGIUM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 181 BELGIUM BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 182 BELGIUM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 183 BELGIUM BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 184 BELGIUM CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 185 BELGIUM BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 186 BELGIUM CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 187 BELGIUM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 188 SWEDEN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 189 SWEDEN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 190 SWEDEN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 191 SWEDEN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 192 SWEDEN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 193 SWEDEN BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 194 SWEDEN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 195 SWEDEN BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 196 SWEDEN CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 197 SWEDEN BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 198 SWEDEN CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 199 SWEDEN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 200 DENMARK CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 201 DENMARK PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 202 DENMARK CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 203 DENMARK CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 204 DENMARK CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 205 DENMARK BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 206 DENMARK CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 207 DENMARK BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 208 DENMARK CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 209 DENMARK BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 210 DENMARK CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 211 DENMARK CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 212 RUSSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 213 RUSSIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 214 RUSSIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 215 RUSSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 216 RUSSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 217 RUSSIA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 218 RUSSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 219 RUSSIA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 220 RUSSIA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 221 RUSSIA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 222 RUSSIA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 223 RUSSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 224 TURKEY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 225 TURKEY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 226 TURKEY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 227 TURKEY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 228 TURKEY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 229 TURKEY BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 230 TURKEY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 231 TURKEY BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 232 TURKEY CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 233 TURKEY BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 234 TURKEY CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 235 TURKEY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 236 NORWAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 237 NORWAY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 238 NORWAY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 239 NORWAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 240 NORWAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 241 NORWAY BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 242 NORWAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 243 NORWAY BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 244 NORWAY CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 245 NORWAY BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 246 NORWAY CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 247 NORWAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 248 FINLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 249 FINLAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 250 FINLAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 251 FINLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 252 FINLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 253 FINLAND BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 254 FINLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 255 FINLAND BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 256 FINLAND CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 257 FINLAND BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 258 FINLAND CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 259 FINLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 260 REST OF EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 261 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 262 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 263 ASIA-PACIFIC PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 264 ASIA-PACIFIC CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 265 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 266 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 267 ASIA-PACIFIC BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 268 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 269 ASIA-PACIFIC BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 270 ASIA-PACIFIC CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 271 ASIA-PACIFIC BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 272 ASIA-PACIFIC CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 273 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 274 CHINA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 275 CHINA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 276 CHINA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 277 CHINA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 278 CHINA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 279 CHINA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 280 CHINA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 281 CHINA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 282 CHINA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 283 CHINA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 284 CHINA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 285 CHINA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 286 JAPAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 287 JAPAN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 288 JAPAN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 289 JAPAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 290 JAPAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 291 JAPAN BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 292 JAPAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 293 JAPAN BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 294 JAPAN CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 295 JAPAN BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 296 JAPAN CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 297 JAPAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 298 SOUTH KOREA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 299 SOUTH KOREA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 300 SOUTH KOREA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 301 SOUTH KOREA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 302 SOUTH KOREA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 303 SOUTH KOREA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 304 SOUTH KOREA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 305 SOUTH KOREA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 306 SOUTH KOREA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 307 SOUTH KOREA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 308 SOUTH KOREA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 309 SOUTH KOREA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 310 INDIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 311 INDIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 312 INDIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 313 INDIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 314 INDIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 315 INDIA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 316 INDIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 317 INDIA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 318 INDIA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 319 INDIA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 320 INDIA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 321 INDIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 322 AUSTRALIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 323 AUSTRALIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 324 AUSTRALIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 325 AUSTRALIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 326 AUSTRALIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 327 AUSTRALIA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 328 AUSTRALIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 329 AUSTRALIA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 330 AUSTRALIA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 331 AUSTRALIA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 332 AUSTRALIA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 333 AUSTRALIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 334 TAIWAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 335 TAIWAN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 336 TAIWAN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 337 TAIWAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 338 TAIWAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 339 TAIWAN BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 340 TAIWAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 341 TAIWAN BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 342 TAIWAN CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 343 TAIWAN BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 344 TAIWAN CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 345 TAIWAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 346 SINGAPORE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 347 SINGAPORE PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 348 SINGAPORE CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 349 SINGAPORE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 350 SINGAPORE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 351 SINGAPORE BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 352 SINGAPORE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 353 SINGAPORE BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 354 SINGAPORE CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 355 SINGAPORE BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 356 SINGAPORE CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 357 SINGAPORE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 358 HONG KONG CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 359 HONG KONG PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 360 HONG KONG CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 361 HONG KONG CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 362 HONG KONG CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 363 HONG KONG BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 364 HONG KONG CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 365 HONG KONG BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 366 HONG KONG CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 367 HONG KONG BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 368 HONG KONG CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 369 HONG KONG CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 370 THAILAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 371 THAILAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 372 THAILAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 373 THAILAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 374 THAILAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 375 THAILAND BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 376 THAILAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 377 THAILAND BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 378 THAILAND CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 379 THAILAND BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 380 THAILAND CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 381 THAILAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 382 MALAYSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 383 MALAYSIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 384 MALAYSIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 385 MALAYSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 386 MALAYSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 387 MALAYSIA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 388 MALAYSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 389 MALAYSIA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 390 MALAYSIA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 391 MALAYSIA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 392 MALAYSIA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 393 MALAYSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 394 INDONESIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 395 INDONESIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 396 INDONESIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 397 INDONESIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 398 INDONESIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 399 INDONESIA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 400 INDONESIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 401 INDONESIA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 402 INDONESIA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 403 INDONESIA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 404 INDONESIA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 405 INDONESIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 406 PHILIPPINES CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 407 PHILIPPINES PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 408 PHILIPPINES CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 409 PHILIPPINES CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 410 PHILIPPINES CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 411 PHILIPPINES BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 412 PHILIPPINES CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 413 PHILIPPINES BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 414 PHILIPPINES CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 415 PHILIPPINES BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 416 PHILIPPINES CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 417 PHILIPPINES CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 418 NEW ZEALAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 419 NEW ZEALAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 420 NEW ZEALAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 421 NEW ZEALAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 422 NEW ZEALAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 423 NEW ZEALAND BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 424 NEW ZEALAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 425 NEW ZEALAND BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 426 NEW ZEALAND CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 427 NEW ZEALAND BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 428 NEW ZEALAND CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 429 NEW ZEALAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 430 REST OF ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 431 SOUTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 432 SOUTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 433 SOUTH AMERICA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 434 SOUTH AMERICA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 435 SOUTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 436 SOUTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 437 SOUTH AMERICA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 438 SOUTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 439 SOUTH AMERICA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 440 SOUTH AMERICA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 441 SOUTH AMERICA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 442 SOUTH AMERICA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 443 SOUTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 444 BRAZIL CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 445 BRAZIL PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 446 BRAZIL CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 447 BRAZIL CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 448 BRAZIL CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 449 BRAZIL BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 450 BRAZIL CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 451 BRAZIL BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 452 BRAZIL CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 453 BRAZIL BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 454 BRAZIL CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 455 BRAZIL CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 456 ARGENTINA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 457 ARGENTINA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 458 ARGENTINA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 459 ARGENTINA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 460 ARGENTINA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 461 ARGENTINA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 462 ARGENTINA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 463 ARGENTINA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 464 ARGENTINA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 465 ARGENTINA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 466 ARGENTINA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 467 ARGENTINA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 468 COLOMBIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 469 COLOMBIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 470 COLOMBIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 471 COLOMBIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 472 COLOMBIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 473 COLOMBIA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 474 COLOMBIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 475 COLOMBIA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 476 COLOMBIA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 477 COLOMBIA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 478 COLOMBIA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 479 COLOMBIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 480 CHILE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 481 CHILE PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 482 CHILE CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 483 CHILE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 484 CHILE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 485 CHILE BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 486 CHILE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 487 CHILE BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 488 CHILE CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 489 CHILE BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 490 CHILE CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 491 CHILE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 492 PERU CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 493 PERU PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 494 PERU CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 495 PERU CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 496 PERU CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 497 PERU BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 498 PERU CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 499 PERU BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 500 PERU CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 501 PERU BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 502 PERU CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 503 PERU CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 504 ECUADOR CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 505 ECUADOR PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 506 ECUADOR CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 507 ECUADOR CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 508 ECUADOR CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 509 ECUADOR BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 510 ECUADOR CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 511 ECUADOR BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 512 ECUADOR CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 513 ECUADOR BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 514 ECUADOR CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 515 ECUADOR CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 516 URUGUAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 517 URUGUAY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 518 URUGUAY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 519 URUGUAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 520 URUGUAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 521 URUGUAY BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 522 URUGUAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 523 URUGUAY BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 524 URUGUAY CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 525 URUGUAY BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 526 URUGUAY CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 527 URUGUAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 528 VENEZUELA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 529 VENEZUELA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 530 VENEZUELA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 531 VENEZUELA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 532 VENEZUELA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 533 VENEZUELA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 534 VENEZUELA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 535 VENEZUELA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 536 VENEZUELA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 537 VENEZUELA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 538 VENEZUELA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 539 VENEZUELA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 540 BOLIVIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 541 BOLIVIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 542 BOLIVIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 543 BOLIVIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 544 BOLIVIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 545 BOLIVIA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 546 BOLIVIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 547 BOLIVIA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 548 BOLIVIA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 549 BOLIVIA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 550 BOLIVIA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 551 BOLIVIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 552 PARAGUAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 553 PARAGUAY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 554 PARAGUAY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 555 PARAGUAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 556 PARAGUAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 557 PARAGUAY BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 558 PARAGUAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 559 PARAGUAY BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 560 PARAGUAY CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 561 PARAGUAY BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 562 PARAGUAY CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 563 PARAGUAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 564 REST OF SOUTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 565 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 566 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 567 MIDDLE EAST AND AFRICA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 568 MIDDLE EAST AND AFRICA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 569 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 570 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 571 MIDDLE EAST AND AFRICA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 572 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 573 MIDDLE EAST AND AFRICA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 574 MIDDLE EAST AND AFRICA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 575 MIDDLE EAST AND AFRICA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 576 MIDDLE EAST AND AFRICA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 577 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 578 SAUDI ARABIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 579 SAUDI ARABIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 580 SAUDI ARABIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 581 SAUDI ARABIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 582 SAUDI ARABIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 583 SAUDI ARABIA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 584 SAUDI ARABIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 585 SAUDI ARABIA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 586 SAUDI ARABIA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 587 SAUDI ARABIA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 588 SAUDI ARABIA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 589 SAUDI ARABIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 590 U.A.E CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 591 U.A.E PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 592 U.A.E CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 593 U.A.E CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 594 U.A.E CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 595 U.A.E BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 596 U.A.E CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 597 U.A.E BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 598 U.A.E CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 599 U.A.E BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 600 U.A.E CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 601 U.A.E CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 602 SOUTH AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 603 SOUTH AFRICA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 604 SOUTH AFRICA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 605 SOUTH AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 606 SOUTH AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 607 SOUTH AFRICA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 608 SOUTH AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 609 SOUTH AFRICA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 610 SOUTH AFRICA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 611 SOUTH AFRICA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 612 SOUTH AFRICA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 613 SOUTH AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 614 EGYPT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 615 EGYPT PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 616 EGYPT CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 617 EGYPT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 618 EGYPT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 619 EGYPT BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 620 EGYPT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 621 EGYPT BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 622 EGYPT CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 623 EGYPT BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 624 EGYPT CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 625 EGYPT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 626 ISRAEL CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 627 ISRAEL PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 628 ISRAEL CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 629 ISRAEL CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 630 ISRAEL CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 631 ISRAEL BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 632 ISRAEL CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 633 ISRAEL BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 634 ISRAEL CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 635 ISRAEL BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 636 ISRAEL CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 637 ISRAEL CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 638 QATAR CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 639 QATAR PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 640 QATAR CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 641 QATAR CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 642 QATAR CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 643 QATAR BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 644 QATAR CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 645 QATAR BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 646 QATAR CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 647 QATAR BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 648 QATAR CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 649 QATAR CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 650 KUWAIT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 651 KUWAIT PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 652 KUWAIT CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 653 KUWAIT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 654 KUWAIT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 655 KUWAIT BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 656 KUWAIT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 657 KUWAIT BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 658 KUWAIT CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 659 KUWAIT BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 660 KUWAIT CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 661 KUWAIT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 662 OMAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 663 OMAN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 664 OMAN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 665 OMAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 666 OMAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 667 OMAN BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 668 OMAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 669 OMAN BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 670 OMAN CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 671 OMAN BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 672 OMAN CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 673 OMAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 674 BAHRAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 675 BAHRAIN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 676 BAHRAIN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 677 BAHRAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2018-2032 (USD THOUSAND)

TABLE 678 BAHRAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 679 BAHRAIN BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 680 BAHRAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 681 BAHRAIN BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 682 BAHRAIN CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 683 BAHRAIN BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 684 BAHRAIN CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 685 BAHRAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 686 REST OF MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

그림 목록

FIGURE 1 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: SEGMENTATION

FIGURE 2 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: DROC ANALYSIS

FIGURE 4 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EXECUTIVE SUMMARY: EUROPE CHINESE HAMSTER OVARY CELLS CHO MARKET

FIGURE 11 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: SEGMENTATION

FIGURE 12 STRATEGIC DECISIONS

FIGURE 13 TWO SEGMENTS COMPRISE THE EUROPE CHINESE HAMSTER OVARY CELLS CHO MARKET, BY TYPE

FIGURE 15 RISING DEMAND FOR BIOLOGICS AND THERAPEUTIC PROTEINS EXPECTED TO DRIVE THE EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET GROWTH IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 16 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET IN THE FORECAST PERIOD OF 2025 & 2032

FIGURE 18 NUMBER OF PATENTS PER COUNTRY OR REGION

FIGURE 19 NUMBER OF PATENTS PER APPLICANTS

FIGURE 20 NUMBER OF PATENTS PER YEAR.

FIGURE 21 DROC ANALYSIS

FIGURE 22 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, 2024

FIGURE 23 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, 2025 TO 2032 (USD THOUSAND)

FIGURE 24 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, CAGR (2025- 2032)

FIGURE 25 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 26 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, 2024

FIGURE 27 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, 2025 TO 2032 (USD THOUSAND)

FIGURE 28 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, CAGR (2025- 2032)

FIGURE 29 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, LIFELINE CURVE

FIGURE 30 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, 2024

FIGURE 31 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, 2025 TO 2032 (USD THOUSAND)

FIGURE 32 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, CAGR (2025- 2032)

FIGURE 33 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 34 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, 2024

FIGURE 35 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, 2025 TO 2032 (USD THOUSAND)

FIGURE 36 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, CAGR (2025- 2032)

FIGURE 37 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, LIFELINE CURVE

FIGURE 38 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY DISTRIBUTION CHANNEL, 2024

FIGURE 39 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2032 (USD THOUSAND)

FIGURE 40 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025- 2032)

FIGURE 41 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 42 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: SNAPSHOT (2022)

FIGURE 43 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: COMPANY SHARE 2024 (%)

FIGURE 44 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: COMPANY SHARE 2024 (%)

FIGURE 45 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: COMPANY SHARE 2024 (%)

FIGURE 46 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: COMPANY SHARE 2024 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

시장은 유럽 ​​중국 햄스터 난소(CHO) 세포 시장 세분화: 유형(서비스 및 제품), 시스템(대사 선택 시스템, 항생제 선택 시스템 등), 응용 분야(생물학적 제제 및 의학 연구), 최종 사용자(바이오제약 회사, 생명공학 회사, 임상 개발 및 제조 기관, 임상 연구 기관, 학술 기관 및 연구 기관 등), 유통 채널(직접 입찰, 소매 판매 등) - 2032년까지 산업 동향 및 전망 기준으로 세분화됩니다.
유럽 ​​중국 햄스터 난소(CHO) 세포 시장의 시장 규모는 2024년에 115.60 USD Million USD로 평가되었습니다.
유럽 ​​중국 햄스터 난소(CHO) 세포 시장는 2025년부터 2032년까지 연평균 성장률(CAGR) 10.1%로 성장할 것으로 예상됩니다.
시장 내 주요 기업으로는 Thermo Fisher Scientific Inc. ,AcceGen ,RayBiotech Life Inc. ,Cytion ,BPS Bioscience Inc.가 포함됩니다.
Testimonial